As antibiotic awareness week continues here in the US (see CDC: Get Smart About Antibiotics Week), and across Europe (European Antibiotic Awareness Day), public health agencies are working to focus public and professional attention on the growing problem of antimicrobial resistance.
This week I’ve paid extra attention to this issue in this blog with several extended reports, including:
And of course, every week is antibiotic awareness week on Maryn McKenna’s Superbug blog.
Carbapenemases are a diverse (and growing) group of bacteria that have developed an enzyme that disrupt the antimicrobial actions of the Carbapenem class of antibiotics – often drugs of last resort when dealing with serious bacterial infections.
This week’s edition of Eurosurveillance is focused almost entirely on the issue of antibiotic resistance, and while some of these articles are of interest primarily to clinicians and researchers, I wanted to pass the links on to my readers.
If you read nothing else, the editorial - Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria – provides an excellent overview of the problem, and is well worth reading.
Eurosurveillance, Volume 15, Issue 46, 18 November 2010
Table of Contents
by ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme
by D Decre, G Birgand, D Geneste, E Maury, JC Petit, F Barbut, G Arlet
by MJ Struelens, DL Monnet, AP Magiorakos, F Santos O’Connor, J Giesecke, the European NDM-1 Survey Participants
by R de Jonge, JE Verdier, AH Havelaar
by H Grundmann, DM Livermore, CG Giske, R Canton, GM Rossolini, J Campos, A Vatopoulos, M Gniadkowski, A Toth, Y Pfeifer, V Jarlier, Y Carmeli, the CNSE Working Group
Surveillance and outbreak reports
by N Kassis-Chikhani, F Saliba, A Carbonne, S Neuville, D Decre, C Sengelin, C Guerin, N Gastiaburu, A Lavigne-Kriaa, C Boutelier, G Arlet, D Samuel, D Castaing, E Dussaix, V Jarlier
by I Willemsen, T van der Kooij, B van Benthem, J Wille, J Kluytmans